摘要
1例23岁女性甲状腺功能亢进症患者接受甲巯咪唑(30mg?d-1)治疗6周后出现多发、游走性关节肿痛,查白细胞、C-反应蛋白水平升高,血沉增快,抗核抗体(ANA)1:320,抗中性粒细胞胞浆抗体(ANCA)、类风湿因子(RF)、抗链球菌溶血素O(ASO)阴性。停用甲巯咪唑1周后症状好转,1月后症状完全缓解,复查抗核抗体1:100。
A 23-year-old female with hyperthyroidism developed migratory polyarthritis 6 weeks after starting therapy with methimazole (30mg daily). Her clinical laboratory tests showed increased total white blood cel count, elevated C-reactive protein level and erythrocyte sedimentation rate and the level of antinuclear antibody (ANA) was 1:320. Test results were negative for the presence of anti-neutrophil cytoplasmic antibodies (ANCAs), rheumatoid factor (RF) and anti-streptolysin O (ASO). Her symptoms were improved 1 week after methimazole was withdrawn, and completely disappeared 1 month later. The test result of ANA analysis was 1:100.
出处
《临床药物治疗杂志》
2014年第6期60-62,共3页
Clinical Medication Journal